路 Researchers state that post-vaccine syndrome is characterized by persistent immune dysregulation & issues with blood coagulation.
路 A drug called dapagliflozin, used to treat Type 2 Diabetes, is being investigated for #LongCOVID in a clinical trial.
路 A double-blind clinical trial is evaluating an experimental drug called REGN7544 for people with postural orthostatic tachycardia syndrome (POTS).
https://thesicktimes.org/2025/05/06/research-updates-may-6/
#ResearchUpdate
Anti. 馃悩
npub1a3鈥uy7v
2025-05-07 08:43:16 UTC
Author Public Key
npub1a3pnvex0xxzkdlpu7dgd3hevzhkhzxynqfrxtcprtcaqk8l2funq7wuy7vSeen on
wss://relay.momostr.pinkPublished at
2025-05-07 08:43:16 UTCEvent JSON
{
"id": "46fdf3d02aeb1258dbc6711bbd6304b3716c591a3096b0d9433136de5bb3ae09",
"pubkey": "ec433664cf318566fc3cf350d8df2c15ed711893024665e0235e3a0b1fea4f26",
"created_at": 1746607396,
"kind": 1,
"tags": [
[
"proxy",
"https://chaos.social/@antiaall3s/114465662342921006",
"web"
],
[
"t",
"longcovid"
],
[
"t",
"researchupdate"
],
[
"proxy",
"https://chaos.social/users/antiaall3s/statuses/114465662342921006",
"activitypub"
],
[
"L",
"pink.momostr"
],
[
"l",
"pink.momostr.activitypub:https://chaos.social/users/antiaall3s/statuses/114465662342921006",
"pink.momostr"
],
[
"-"
]
],
"content": "路 Researchers state that post-vaccine syndrome is characterized by persistent immune dysregulation \u0026 issues with blood coagulation.\n\n路 A drug called dapagliflozin, used to treat Type 2 Diabetes, is being investigated for #LongCOVID in a clinical trial.\n\n路 A double-blind clinical trial is evaluating an experimental drug called REGN7544 for people with postural orthostatic tachycardia syndrome (POTS).\n\nhttps://thesicktimes.org/2025/05/06/research-updates-may-6/\n\n#ResearchUpdate",
"sig": "9bba667a75a6d420e2b552a50777b80bd4aaed23e0a982d8cfc80acf745a4a9e41434b444074acf7b3d913e06f6a390ceb48c52dab0cde402ecc0a2ea960745b"
}